Lazertinib mesylate monohydrate
N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide;methanesulfonic acid;hydrate
Molecular Identity
Lazertinib mesylate monohydrate
N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide;methanesulfonic acid;hydrate
PubChem CID: 163203547
2D Structure
Properties
C31H40N8O7S
Molecular Formula
668.80
Molecular Weight
g/mol
668.2741
Exact Mass
Da
173
TPSA
May have limited oral absorption
4
H-Bond Donors
13
H-Bond Acceptors
929
Complexity
SMILES
Canonical SMILES
SMILES: CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC.CS(=O)(=O)O.OIsomeric SMILES
SMILES: CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC.CS(=O)(=O)O.OSynonyms(20)
Lazertinib mesilate hydrateLazertinib mesylate monohydrateWUT449BEG52411549-88-5Lazertinib mesilate hydrate [JAN]Lazertinib mesylate monohydrate [WHO-DD]2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-, methanesulfonate, hydrate (1:1:1)Lazertinib mesilate hydrate (JAN)2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]-, methanesulfonate, hydrate (1:1:1)RefChem:201446Lazertinib MesylateUNII-WUT449BEG5YH25448AMJNJ-73841937-ZCYLazertinib mesylate (USAN)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Lazertinib mesylate monohydrate
Loading drug network...